Anti-SAA1 + SAA2 antibody [EPR19550]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Recombinant Monoclonal Serum Amyloid A 1 antibody. Suitable for WB, IHC-P and reacts with Recombinant fragment - Human, Human, Recombinant fragment samples. Cited in 11 publications.
View Alternative Names
Serum amyloid A-1 protein, SAA, SAA1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SAA1 + SAA2 antibody [EPR19550] (AB207445)
Immunohistochemical analysis of paraffin-embedded human liver cancer tissue labeling SAA1+SAA2 with ab207445 at 1/1000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Cytoplasmic staining on human liver cancer is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SAA1 + SAA2 antibody [EPR19550] (AB207445)
Immunohistochemical analysis of paraffin-embedded human liver tissue labeling SAA1+SAA2 with ab207445 at 1/1000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Cytoplasmic staining on human liver is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-SAA1 + SAA2 antibody [EPR19550] (AB207445)
Blocking/Dilution buffer : 5% NFDM/TBST.
Expressed by the liver; secreted in plasma and serum (PMID : 3183061; PMID : 16039662).
All lanes:
Western blot - Anti-SAA1 + SAA2 antibody [EPR19550] (ab207445) at 1/1000 dilution
All lanes:
Human liver lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 13 kDa
Observed band size: 13 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-SAA1 + SAA2 antibody [EPR19550] (AB207445)
Blocking/Dilution buffer : 5% NFDM/TBST.
Expressed by the liver; secreted in plasma and serum (PMID : 3183061; PMID : 16039662).
All lanes:
Western blot - Anti-SAA1 + SAA2 antibody [EPR19550] (ab207445) at 1/5000 dilution
All lanes:
Human serum at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 13 kDa
Observed band size: 13 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-SAA1 + SAA2 antibody [EPR19550] (AB207445)
Blocking/Dilution buffer : 5% NFDM/TBST.
Human SAA2 and SAA4 fragment recombinant protein contain aa19-122 and aa19-130 with His-Tag® and GST-tag.
All lanes:
Western blot - Anti-SAA1 + SAA2 antibody [EPR19550] (ab207445) at 1/1000 dilution
Lane 1:
Human SAA1 active recombinant protein at 0.01 µg
Lane 2:
Human SAA2 fragment recombinant protein at 0.01 µg
Lane 3:
Human SAA4 fragment recombinant protein at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 13 kDa
Observed band size: 13 kDa,35 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-SAA1 + SAA2 antibody [EPR19550] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
These proteins mediate several processes involving immune modulation and cholesterol efflux. SAA1 and SAA2 both function as apolipoproteins primarily associated with high-density lipoprotein (HDL) in plasma. Researchers have identified them as part of a complex of circulating acute-phase proteins that interact with cell surface receptors on various immune cells influencing leukocyte recruitment and adhesion. This interaction facilitates an effective immune response to injury or infection.
Pathways
SAA1 and SAA2 participate significantly in the acute-phase response and cholesterol metabolism pathways. These proteins enhance the transport of cholesterol to the liver for secretion into the bile. Their interaction with proteins like apolipoprotein A-I highlights their role in lipid metabolism. The Toll-like receptor pathways which are vital for innate immunity also see modulation by SAA1 and SAA2 impacting the expression of cytokines involved in inflammatory signaling.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:6770 PubMed40695827
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:31233 PubMed39732788
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell discovery 10:115 PubMed39557828
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:4960 PubMed37620307
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell research 33:585-603 PubMed37337030
2023
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 13:187 PubMed35525990
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer science 112:2173-2184 PubMed33626219
2021
Applications
Unspecified application
Species
Unspecified reactive species
iScience 24:102483 PubMed34113824
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell 180:79-91.e16 PubMed31866067
2019
Applications
Unspecified application
Species
Unspecified reactive species
EBioMedicine 41:185-199 PubMed30773478
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com